Is Carfilzomib a Chemotherapy Medicine? How it is Administered?
Carfilzomib is a type of chemotherapy medicine and a second-generation proteasome inhibitor. It is used to treat Multiple Myeloma, a B-cell malignancy in which there is an expansion as well as accumulation of abnormal plasma cells in the bone marrow, which accounts for 10% of all hematologic cancers. Plasma cells are found in the soft tissue inside bones known as bone marrow. They are an indispensable part of the immune system and form antibodies that fight and demolish foreign invaders. When an individual has MM, their plasma cells grow and progress out of control. Carfilzomib injection is supplied under the brand name Kyprolis. It is a chemotherapy medicine that is widely used to treat individuals with relapsed or refractory multiple myeloma (RRMM): along with dexamethasone or with lenalidomide plus dexamethasone in individuals who have previously received three therapies. as a standalone medicine for those who received one or more therapies. How Carfilzomib is Administration: Carfi